Fingerprint
Dive into the research topics of 'Efficacy of STI571, an Abl tyrosine kinase inhibitor, in conjunction with other antileukemic agents against Bcr-Abl-positive cells'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Efficacy of STI571, an Abl tyrosine kinase inhibitor, in conjunction with other antileukemic agents against Bcr-Abl-positive cells
J. Tyler Thiesing, Sayuri Ohno-Jones, Kathryn S. Kolibaba, Brian J. Druker
Research output: Contribution to journal › Article › peer-review
319
Scopus
citations